The UK has some of the world’s most valuable health and care data. From birth records to cancer treatments, from GP visits to hospital stays, the NHS holds information that could unlock breakthrough treatments for millions of people worldwide. But right now, that potential is locked away in fragmented systems that makes research unnecessarily difficult […]
As benefits lead for the NHS Federated Data Platform (NHS FDP), I’m often asked what we mean when we talk about “benefits”. It’s a fair question and one that deserves a thoughtful answer. What are benefits in the NHS FDP context? At its core, a benefit is a measurable improvement that delivers real value to […]
Did you know the NHS runs the second-largest vehicle fleet in the country — just behind Royal Mail? With over 20,000 vehicles clocking up more than 460 million miles each year, our fleet plays a vital role in delivering NHS services. From ambulances and patient transport to maintenance and essential deliveries, these vehicles help keep […]
When I think about what makes digital transformation meaningful, it always comes back to one thing: people. The Single Patient Record (SPR) is no different. The creation of a single patient record is a central commitment in the 10 Year Health Plan. It sets out our ambition to give patients real control over their data […]
Organ transplants not only save lives, they transform them. For our vital organs like hearts and lungs the impact of a transplant is priceless, and transcends not only immediate clinical outcomes, but also the long term impact on families and loved ones of donors and recipients. We often talk about ‘life-course’ interventions in health care; […]
At NHS England, our hepatitis C elimination programme has been a model for international efforts to eliminate the virus. The programme has identified and treated tens of thousands of people living with hepatitis C, preventing them from going on to develop life-threatening liver disease and cancers. As we recognise World Hepatitis Day, today marks an […]
As National Clinical Director for Cancer, I am delighted to confirm that two new National Clinical Leads for Cancer Drugs have been appointed to replace Professor Peter Clark, who played such a leading role in making sure NHS patients had the best possible access to new cancer treatments. Professor Ruth Plummer, Clinical Professor of Experimental […]
